BOCA RATON, Fla.–(BUSINESS WIRE)–TXMD entered label discussions with FDA for TX-001HR; PDUFA target action date for the completion of the FDA’s review of the NDA is Oct. 28, 2018
BOCA RATON, Fla.–(BUSINESS WIRE)–TXMD entered label discussions with FDA for TX-001HR; PDUFA target action date for the completion of the FDA’s review of the NDA is Oct. 28, 2018